Controversy over domestic drugmaker Medigen’s COVID-19 vaccine could have been avoided had the company published data on its phase 2 clinical trials in international journals, National Taiwan University (NTU) College of Public Health vice dean Tony Chen (陳秀熙) said yesterday.
The government on Sunday granted emergency use authorization (EUA) to the Medigen jab after an expert panel said that antibody levels in the blood of phase 2 trial participants met local standards.
However, critics said that the experts’ reasoning was not convincing because not all trial data had been publicized and that Taiwan is the only country to conditionally approve a vaccine that has not yet passed phase 3 clinical trials.
Medigen on Tuesday said it had received approval to conduct phase 3 trials on 1,000 people in Paraguay.
Chen yesterday said that the Paraguay trials’ methodology and safety precautions would be well within international standards, but whether the vaccine could provide sufficient protection, especially against highly infectious variants of SARS-CoV-2, could only be determined with additional trials.
Chen said that he believes the expert panels’ assessment on which the EUA is based, but that the company lacks sufficient credibility based on publication in scientific journals.
“Trial data of the COVID-19 vaccines that are in use worldwide — AstraZeneca, Pfizer-BioNTech, Moderna, Johnsons & Johnson and Novavax, among others — have been published in credible international journals,” Chen said, adding that this, not the transparency of the approval process in various countries, gives them credibility.
Even China last year publicized the phase 2 trial results of the Sinovac COVID-19 vaccine, he said.
The publication of trial data is a critical step that the Medigen vaccine must take, Chen said, adding that verification by the international medical community would be crucial to calm the worries of Taiwanese.
Taoyuan Mayor Cheng Wen-tsan (鄭文燦) and Tainan Mayor Huang Wei-che (黃偉哲), both of the Democratic Progressive Party, have said that they would be willing to receive the Medigen vaccine as their second shot, while New Taipei City Mayor Hou You-yi (侯友宜) of the Chinese Nationalist Party (KMT) has said that the jab’s efficacy should first be determined by the scientific community, not by politics.
Transparency is key to winning public support, Hou said, adding that public support is key to whether the Medigen jab would become widely accepted.
Additional reporting by Lai Hsiao-tung
Taiwan has received more than US$70 million in royalties as of the end of last year from developing the F-16V jet as countries worldwide purchase or upgrade to this popular model, government and military officials said on Saturday. Taiwan funded the development of the F-16V jet and ended up the sole investor as other countries withdrew from the program. Now the F-16V is increasingly popular and countries must pay Taiwan a percentage in royalties when they purchase new F-16V aircraft or upgrade older F-16 models. The next five years are expected to be the peak for these royalties, with Taiwan potentially earning
STAY IN YOUR LANE: As the US and Israel attack Iran, the ministry has warned China not to overstep by including Taiwanese citizens in its evacuation orders The Ministry of Foreign Affairs (MOFA) yesterday rebuked a statement by China’s embassy in Israel that it would evacuate Taiwanese holders of Chinese travel documents from Israel amid the latter’s escalating conflict with Iran. Tensions have risen across the Middle East in the wake of US and Israeli airstrikes on Iran beginning Saturday. China subsequently issued an evacuation notice for its citizens. In a news release, the Chinese embassy in Israel said holders of “Taiwan compatriot permits (台胞證)” issued to Taiwanese nationals by Chinese authorities for travel to China — could register for evacuation to Egypt. In Taipei, the ministry yesterday said Taiwan
Taiwan is awaiting official notification from the US regarding the status of the Agreement on Reciprocal Trade (ART) after the US Supreme Court ruled US President Donald Trump's global tariffs unconstitutional. Speaking to reporters before a legislative hearing today, Premier Cho Jung-tai (卓榮泰) said that Taiwan's negotiation team remains focused on ensuring that the bilateral trade deal remains intact despite the legal challenge to Trump's tariff policy. "The US has pledged to notify its trade partners once the subsequent administrative and legal processes are finalized, and that certainly includes Taiwan," Cho said when asked about opposition parties’ doubts that the ART was
If China chose to invade Taiwan tomorrow, it would only have to sever three undersea fiber-optic cable clusters to cause a data blackout, Jason Hsu (許毓仁), a senior fellow at the Hudson Institute and former Chinese Nationalist Party (KMT) legislator, told a US security panel yesterday. In a Taiwan contingency, cable disruption would be one of the earliest preinvasion actions and the signal that escalation had begun, he said, adding that Taiwan’s current cable repair capabilities are insufficient. The US-China Economic and Security Review Commission (USCC) yesterday held a hearing on US-China Competition Under the Sea, with Hsu speaking on
RSS